CN107056788A - A kind of imidazolidinone analog derivative and its synthetic method - Google Patents
A kind of imidazolidinone analog derivative and its synthetic method Download PDFInfo
- Publication number
- CN107056788A CN107056788A CN201710176452.9A CN201710176452A CN107056788A CN 107056788 A CN107056788 A CN 107056788A CN 201710176452 A CN201710176452 A CN 201710176452A CN 107056788 A CN107056788 A CN 107056788A
- Authority
- CN
- China
- Prior art keywords
- octane
- cyclohexyl
- synthesis
- dicarbapentaborane
- tertbutyloxycarbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of imidazolidinone analog derivative and its synthetic method, the derivative it is entitled(5S)3 cyclohexyl, 2,4 dicarbapentaborane 1,3 diazabicyclo [3,3,0] octane, its synthetic method is carried out according to the following steps:First step is synthesis N tertbutyloxycarbonyl L proline, and second step is synthesis N tertbutyloxycarbonyl L prolyl dicyclohexylurea (DCU)s, and third step is synthesis(5S)3 cyclohexyl, 2,4 dicarbapentaborane 1,3 diazabicyclo [3,3,0] octane.Reactions steps of the present invention are less, yield is higher, reactions steps are more when avoiding synthesis imidazolidine ketone compounds in the past, post processing is complicated, the low defect of yield, prepare a kind of new imidazolidinone derivatives, disclosure satisfy that the demand of industrialized production imidazolidine ketone compounds.
Description
Technical field
The invention belongs to organic chemistry filed, it is related to a kind of imidazolidinone derivatives and its synthetic method.
Background technology
Natural amino acid ABUNDANT NATUREAL RESOURSES, many amino acid derivativges have good bioactivity, and this to be based on
The synthesis of amino acid derivativges increasingly becomes the focus of people's research.Imidazolidinone analog derivative treatment diabetes (referring to
WO2009132986A1) and in terms of hepatitis (referring to US20090099186A1) there is preferable bioactivity, can directly make
Used for pharmaceutical intermediate.However, imidazolidine ketone compounds(That is imidazolidinone analog derivative), especially some special miaows
The synthesis technique of (oxazolidinon-5-yl-methyl)-2-thiophene-carboxamides derivative has the shortcomings that reactions steps are more, post processing is complicated, low yield mostly, it is difficult to directly use
In industrialized production.Therefore, new imidazolidine ketone compounds are researched and developed, its synthetic method is explored, meets industrial production demand
Turn into active demand.
The content of the invention
It is an object of the invention to provide a kind of new imidazolidinone analog derivative, and it is less to provide a kind of reactions steps,
The higher synthetic method of yield.
To achieve the above object, the invention provides a kind of imidazolidinone analog derivative, the derivative it is entitled(5S)-
3- cyclohexyl -2,4- dicarbapentaborane -1,3- diazabicyclo [3,3,0] octane, its structural formula is:
It is above-mentioned(5S)The synthetic method of -3- cyclohexyl -2,4- dicarbapentaborane -1,3- diazabicyclos [3,3,0] octane presses following step
It is rapid to carry out:
First step is added to L-PROLINE in the mixed liquor of the tert-butyl alcohol and the NaOH aqueous solution, at room temperature while stirring in batches
Di-tert-butyl dicarbonate is added, after reaction terminates, through extraction, is acidified, dries, filtering removes solvent under reduced pressure, obtains N- tertiary butyloxycarbonyls
Base-L-PROLINE;The molecular formula of the di-tert-butyl dicarbonate is:((CH3)3COCO)2O, is abbreviated as(Boc)2O。
Second step is that N- tertbutyloxycarbonyls-L-PROLINE is added in dichloromethane, then adds dicyclohexyl carbon
Diimine, stirring reaction, filtering, are concentrated to give N- tertbutyloxycarbonyl-L- prolyl dicyclohexylurea (DCU)s at room temperature;
Third step is N- tertbutyloxycarbonyl-L- prolyl dicyclohexylurea (DCU) acetone solutions, adds concentrated hydrochloric acid, and room temperature is anti-
Should, then it is neutralized to alkalescent(Alkalescent refers to pH value higher than 7 and less than or equal to 8.5 herein), through extraction, dry, filtering subtracts
Solvent is evaporated off in pressure, produces(5S)- 3- cyclohexyl -2,4- dicarbapentaborane -1,3- diazabicyclos [3,3,0] octane.
The reaction equation of above-mentioned three step reaction is:
The synthetic method route of the present invention is simple, and step only has three steps, and reaction condition is gentle, easy to operate, high income, up to 75%
More than, it is adapted to industrialized production.(5S)- 3- cyclohexyl -2,4- dicarbapentaborane -1,3- diazabicyclos [3,3,0] octane is imidazoles
Alkanone derivative(That is imidazolidine ketone compounds)One kind, and imidazolidine ketone compounds treatment diabetes and hepatitis etc. side
Face has preferable bioactivity(Referring to WO2009132986A1 and US20090099186A1), can be directly as in medicine
Mesosome is used.
Reactions steps of the present invention are less, and yield is higher, it is to avoid reactions steps during conventional synthesis imidazolidine ketone compounds
Many, post processing is complicated, the low defect of yield, prepares a kind of new imidazolidinone derivatives, disclosure satisfy that industrialized production miaow
The demand of oxazolidinones.
Brief description of the drawings
Fig. 1 is(5S)The X-ray monocrystalline of -3- cyclohexyl -2,4- dicarbapentaborane -1,3- diazabicyclos [3,3,0] octane spreads out
Penetrate figure.
Embodiment
With reference to Fig. 1, the invention provides a kind of imidazolidinone analog derivative, the derivative it is entitled(5S)- 3- hexamethylenes
Base -2,4- dicarbapentaborane -1,3- diazabicyclo [3,3,0] octane, its structural formula is:
Its synthetic method is carried out according to the following steps:
First step is synthesis N- tertbutyloxycarbonyls-L-PROLINE, is specifically by L-PROLINE(5.75g, 50mmol)It is added to
The tert-butyl alcohol(70 mL)And NaOH(3.2 g, 80 mmol)The aqueous solution(70 mL)Mixed liquor in, at room temperature while stirring in batches
Add di-tert-butyl dicarbonate(12.0 g, 55 mmol), continue to stir 12 hours, after reaction terminates, through extraction, be acidified, do
Dry, filtering removes solvent under reduced pressure, obtains N- tertbutyloxycarbonyls-L-PROLINE;
Wherein, the molecular formula of di-tert-butyl dicarbonate is:((CH3)3COCO)2O, is abbreviated as(Boc)2O;Extraction is to use acetic acid second
Ester extraction is excessive to remove(Boc)2O, is then extracted with ethyl acetate after acidulation;Acidifying refers to use watery hydrochloric acid acidifying water
It is about 3 mutually to make pH;The drying refers to after being extracted with ethyl acetate, and uses anhydrous sodium sulfate drying;The tertiary fourths of N- obtained by this step
Oxygen carbonyl-L-PROLINE is white solid, yield 94%.Fusing point is 119.5 ~ 121.0 DEG C.
Second step be synthesis N- tertbutyloxycarbonyl-L- prolyl dicyclohexylurea (DCU)s, be specifically by N- tertbutyloxycarbonyls-
L-PROLINE(2.15g, 10mol)It is added in dry dichloromethane, dicyclohexylcarbodiimide is then added while stirring
(2.06 g, 10 mmol), stirring reaction 12 hours, filtering, remove solvent concentration under reduced pressure and obtain N- tertbutyloxycarbonyls-L- at room temperature
Prolyl dicyclohexylurea (DCU);N- tertbutyloxycarbonyl-L- prolyls dicyclohexylurea (DCU) obtained by this step is colourless viscous liquid
(Colorless oil), yield is 87%.
The proton nmr spectra of N- tertbutyloxycarbonyl-L- prolyl dicyclohexylurea (DCU)s obtained by this step and carbon spectrum spectra count
According to as follows:
1H NMR (400 MHz, CDCl3)δ:1.26~1.55 (m, 21H, -CH2CH2-CH2- ,-C(CH3)3), 1.73~
1.96 (m, 12H, -CH 2 CH 2 -CH-), 3.40~3.56 (m, 3H, -NCH-), 4.17~4.42 (m,1H, -NCH-),
4.45~4.48 (m, 1H, --NCHCO-), 13C NMR (CDCl3) δ: 171.7, 155.0, 154.2, 80.2,
59.1, 54.4, 50.0, 48.9, 32.7, 31.8, 31.6, 31.3, 29.1, 28.4, 28.3, 26.1, 25.9,
25.6, 25.4, 24.6. MS (ESI):m/z cacld. for C23H39N3O4 (M+Na)+444.3, found 444.2。
Third step is synthesis(5S)- 3- cyclohexyl -2,4- dicarbapentaborane -1,3- diazabicyclo [3,3,0] octane, specifically
It is:By the N- tertbutyloxycarbonyl-L- prolyl dicyclohexylurea (DCU) acetone solutions obtained by second step, concentrated hydrochloric acid, room are added
Temperature reaction 24 hours, is then neutralized to alkalescent with aqueous sodium carbonate(Alkalescent refers to pH value higher than 7 and is less than or equal to herein
8.5, preferred value is 8.0), extracted through ethyl acetate, anhydrous sodium sulfate drying, filter, remove solvent under reduced pressure, made with ethyl acetate
For solvent recrystallization, produce(5S)- 3- cyclohexyl -2,4- dicarbapentaborane -1,3- diazabicyclos [3,3,0] octane.Wherein, dense salt
The mass percent concentration of acid is 30%-38%, and preferred value is 35%.
(5S)The proton nmr spectra and carbon of -3- cyclohexyl -2,4- dicarbapentaborane -1,3- diazabicyclos [3,3,0] octane
Modal data is as follows:
1H NMR (400 MHz, CDCl3)δ:1.16~2.25 (m, 14H, -CH2CH2-), 3.19~3.25 (m, 1H, -
NCH-), 3.64~3.83 (m, 2H, -NCH2-), 3.97~4.01 (m, 1H, -NCHCO-), 13C NMR (CDCl3)δ: 174.0, 160.9, 62.8, 51.7, 45.6, 29.3, 29.1, 27.7, 26.8, 25.8, 25.0.
[α]D 20:–113.0° (c 1.0, CHCl3)。
" room temperature " in above steps, scope preferably is 25 ± 5 DEG C, and optimum value is 25 DEG C.
Above example is only used to illustrative and not limiting technical scheme, although with reference to above-described embodiment to this hair
It is bright to be described in detail, it will be understood by those within the art that:Still the present invention can be modified or be waited
With replacement, any modification or partial replacement without departing from the spirit and scope of the present invention, it all should cover the power in the present invention
Among sharp claimed range.
Claims (2)
1. a kind of imidazolidinone analog derivative, it is characterised in that:The derivative it is entitled(5S)The carbonyls of -3- cyclohexyl -2,4- two
Base -1,3- diazabicyclo [3,3,0] octane, structural formula is:
。
2. synthesize described in claim 1(5S)- 3- cyclohexyl -2,4- dicarbapentaborane -1,3- diazabicyclos [3,3,0] octane
Method, it is characterised in that carry out according to the following steps successively:
First step is synthesis N- tertbutyloxycarbonyls-L-PROLINE, is specifically that L-PROLINE is added into the tert-butyl alcohol and NaOH water
In the mixed liquor of solution, di-tert-butyl dicarbonate is added portionwise while stirring at room temperature, after reaction terminates, through extraction, is acidified, does
Dry, filtering removes solvent under reduced pressure, obtains N- tertbutyloxycarbonyls-L-PROLINE;
Second step is synthesis N- tertbutyloxycarbonyl-L- prolyl dicyclohexylurea (DCU)s, is specifically by N- tertbutyloxycarbonyl-L- dried meat
Propylhomoserin is added in dichloromethane, then adds dicyclohexylcarbodiimide, at room temperature stirring reaction, filtering, is concentrated to give uncle N-
Butoxy carbonyl-L- prolyl dicyclohexylurea (DCU)s;
Third step is synthesis(5S)- 3- cyclohexyl -2,4- dicarbapentaborane -1,3- diazabicyclo [3,3,0] octane, be specifically:
N- tertbutyloxycarbonyl-L- prolyl dicyclohexylurea (DCU) acetone solutions, add concentrated hydrochloric acid, and then room temperature reaction is neutralized to weak
Alkalescence, through extraction, is dried, and filtering removes solvent under reduced pressure, produced(5S)- 3- cyclohexyl -2,4- dicarbapentaborane -1,3- diazas are double
Ring [3,3,0] octane.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710176452.9A CN107056788A (en) | 2017-03-23 | 2017-03-23 | A kind of imidazolidinone analog derivative and its synthetic method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710176452.9A CN107056788A (en) | 2017-03-23 | 2017-03-23 | A kind of imidazolidinone analog derivative and its synthetic method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107056788A true CN107056788A (en) | 2017-08-18 |
Family
ID=59620886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710176452.9A Pending CN107056788A (en) | 2017-03-23 | 2017-03-23 | A kind of imidazolidinone analog derivative and its synthetic method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107056788A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105693817A (en) * | 2014-11-27 | 2016-06-22 | 西北大学 | Tripeptide compound and preparation method and application thereof |
-
2017
- 2017-03-23 CN CN201710176452.9A patent/CN107056788A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105693817A (en) * | 2014-11-27 | 2016-06-22 | 西北大学 | Tripeptide compound and preparation method and application thereof |
Non-Patent Citations (3)
Title |
---|
ANAS LATAIFEH等: "Formation of N-(1-ferrocenoylpyrrolidine-2-carbonyl)-N,N0-dicyclohexylurea: Dead-end in the preparation of ferrocene-modified peptides", 《INORGANICA CHIMICA ACTA》 * |
ISSARTEL, V.等: "New 7-hydroxy-1,3-diazabicyclo[3.3.0]octane derivatives: evaluation of their in vitro immunomodulating effects", 《EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY》 * |
SCHON, I.等: "Side reactions during the removal of protecting groups of N-(protected aminoacyl)urea derivatives", 《ACTA CHIMICA ACADEMIAE SCIENTIARUM HUNGARICAE》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104356197B (en) | A kind of Carfilzomib intermediate and preparation method thereof, and a kind of preparation method of Carfilzomib | |
CN106699756A (en) | Method for synthesizing beta-lactamase inhibitor Avibactam | |
CN106349185A (en) | Amino-protected 3-hydroxy adamantane glycine benzothiazole-2-thiol active ester as well as preparation method and application thereof | |
CN105254575A (en) | Synthetic method for sulfadiazine | |
CN104592081B (en) | A kind of synthetic method of aztreonam main ring | |
CN106565607B (en) | A kind of synthetic method of N-BETA-Alanyl-L-histidine | |
CN106631777B (en) | Synthesize γ-chlorobutanoate method | |
CN108033903A (en) | Synthesis process for D L-p-methylsulfonylphenylserine ethyl ester with water esterification | |
CN107056788A (en) | A kind of imidazolidinone analog derivative and its synthetic method | |
CN112062704B (en) | Preparation method of trifluoromethylated polypeptide compound | |
CN109438307A (en) | A kind of preparation method of L- selenomethionine | |
CN112745254A (en) | Preparation method and application of 4-hydroxy-2-oxo-1-pyrrolidine acetic acid | |
CN115197150A (en) | Preparation method of L-carnosine | |
CN112679407A (en) | Preparation method of chiral 5-substituted proline compound | |
CN104910068B (en) | A kind of synthetic method of the tosilate of 2 cyano group isonicotinic acid hydrazide 1.5 | |
CN107098950A (en) | A kind of synthetic method of GHK or AHK tripeptides | |
CN102286000A (en) | Preparation method of cefonicid and medicinal salts thereof | |
CN113956266A (en) | Method for synthesizing tetrodotoxin on large scale | |
CN112358528B (en) | Preparation method of glutathione | |
CN103435530A (en) | Preparation method of D-tryptophan lower alcohol ester hydrochloride with high optical purity | |
CN103922985B (en) | A kind of synthetic method of azetidinone | |
CN112625086B (en) | Preparation method of argatroban impurity G | |
CN107089928A (en) | The synthetic method of N Boc L propargylglycines | |
CN104371001B (en) | The technique of synthesis of high purity Ganguertai in mixed solvent | |
CN113087654B (en) | Preparation method of piperidine-4-butylamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170818 |